Lymphoma, Low-Grade Completed Phase 2 Trials for Rituximab (DB00073)
Also known as: Low-Grade Lymphoma
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029914 (Lymphoma, Low-Grade) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00311129 | Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL | Treatment |